SHBG and Free Testosterone describes the critical, inverse regulatory relationship between Sex Hormone-Binding Globulin (SHBG), a liver-synthesized transport protein, and the concentration of biologically active Free Testosterone in the circulation. SHBG binds tightly to testosterone, effectively rendering it inactive and unavailable to target tissues. Consequently, high SHBG levels reduce the free, active fraction of testosterone, even if the total testosterone concentration appears within the normal range.
Origin
This pairing is fundamental to clinical endocrinology, particularly in the assessment of androgen status. SHBG was identified as the primary carrier protein for sex hormones, leading to the necessary distinction between total and ‘Free Testosterone’ to accurately interpret clinical symptoms of androgen status.
Mechanism
SHBG acts as a major regulator of testosterone bioavailability, controlling its delivery to peripheral tissues. Factors like aging, estrogen excess, or certain metabolic conditions can increase SHBG production, sequestering more testosterone and reducing the free fraction. Clinical management often involves assessing and modulating SHBG levels to ensure an optimal concentration of physiologically active free testosterone for muscle, bone, and cognitive health.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.